Using Bremelanotide Intranasal Spray To Treat HSDD
The food and drug administration in the United States approved Bremelanotide to treat women’s sexual health problems like low sexual desire in women before menopausal. So bremelanotide is used to treat generalized hypoactive sexual desire disorder or acquired hypoactive sexual desire disorder. Bremelanotide is sold under the name Vyleesi.
Hypoactive
sexual desire disorder (HSDD) is a condition that
is marked not only by low sexual desire but also by distress, relationship
difficulties, mental health conditions, etc. Generalized Hypoactive sexual
desire disorder develops in women that experience problems with their sexual
desire regardless of the situation, partner, and type of sexual activity.
Whereas, acquired hypoactive sexual desire disorder occurs in women who did not
face any kind of sexual desire problems before in life.
Vyleesi or bremelanotide
intranasal spray helps to activate the melanocortin receptors in women. These
receptors are used to improve sexual desire in women. Bremelanotide intranasal
spray is only to be used to treat low sexual desire that is caused under
particular sexual circumstances, with a particular sex partner, or any type of
sexual activity. It must not be confused with low
sexual desire due to menopause, relationship problems, health
conditions, drug abuse, medications, etc. Also, keep in mind that bremelanotide
should not be used to improve performance during sex.
Dosage
of bremelanotide intranasal spray
The dosage of bremelanotide
intranasal spray depends upon the intensity of symptoms and the health
condition of the patient. The spray contains 21 mg or 0.3 ml of contents. It
must be taken about 45-60 mins before having any kind of sexual activity
through a nostril. It is generally prescribed not to take more than one
bremelanotide dose within a day and no more than 8 doses in a month.
Effects
of bremelanotide
The common effects
of using bremelanotide nasal spray include:
●
Nausea
●
Hot flashes
●
Cough
●
Flu
●
Dizziness
●
Tiredness
●
Headache
DO NOT USE
●
If you have cardiovascular or
blood pressure issues
●
During pregnancy
● During breastfeed
Bremelanotide Nasal Spray has been clinically studied in women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty that is NOT due to: A co-existing medical or psychiatric condition.
ReplyDelete